Vir Biotechnology, Inc. — Director's Dealing 2020

Aug 21, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2020-08-19

Reporting Person: Pang Phillip (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-19	Common Stock	M	10185	$1.575	Acquired	25962	Direct
2020-08-19	Common Stock	M	2315	$5.175	Acquired	28277	Direct
2020-08-19	Common Stock	M	14000	$0.855	Acquired	42277	Direct
2020-08-19	Common Stock	S	5000	$50.9615	Disposed	37277	Direct
2020-08-19	Common Stock	S	7500	$50.9397	Disposed	29777	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-19	Employee Stock Option (Right to Buy)	$1.575	M	10185	Disposed	2028-07-19	Common Stock (10185)	Direct
2020-08-19	Employee Stock Option (Right to Buy)	$5.175	M	2315	Disposed	2029-03-11	Common Stock (2315)	Direct
2020-08-19	Employee Stock Option (Right to Buy)	$0.855	M	14000	Disposed	2027-03-09	Common Stock (14000)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020.

F2: 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.

F3: 1/4 of the shares subject to the stock option vested and became exercisable on March 11, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter.

F4: The total number of shares remaining under this stock option has been adjusted by 50 shares to correct a typographical error that occurred in the reporting person's Form 4 filed July 2, 2020. The total number of shares remaining under this stock option following the transaction reported on July 2, 2020 was underreported by 50 shares.

F5: 1/4 of the 111,110 shares originally subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vest in 36 equal monthly installments thereafter.